Roche Holding AG: Focus on Personalized Medicine Pays Off
Reading Time: 2 minutes
The Roche Holding AG is the undisputed global leader in oncology and a pioneer of personalized medicine. The company's solution offering is based on a unique structure that arises from the close integration of the powerful pharmaceutical division with the world's leading diagnostics division. This symbiosis allows Roche to pair tailored therapeutic agents directly with the appropriate companion diagnostics, thereby maximizing treatment efficiency for patients and avoiding unnecessary therapies. A key success for the pharmaceutical division...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
